p53 oncogene mutations in human prostate cancer specimens
- PMID: 7904314
- DOI: 10.1016/s0022-5347(17)35000-0
p53 oncogene mutations in human prostate cancer specimens
Abstract
Eighty-five prostate cancer specimens from prostate resections were analyzed for the presence of p53 gene mutations by immunohistochemical staining for P53 protein. DNA from thirty-four of these samples was also analyzed for mutations in exons 5-8 by single-strand chain polymorphism (SSCP) analysis. One sample had P53 staining by immunohistochemistry, one sample was positive for a p53 mutation by SSCP, and one sample was positive by both techniques. Mutations in the two samples that were positive by SSCP were confirmed by nucleotide sequencing. In a separate study of ten lymph nodes that contained prostate cancer metastases, one had detectable P53 protein by immunohistochemical staining. Therefore, p53 mutations appear to be low frequency events in primary prostate cancer.
Similar articles
-
p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.J Natl Cancer Inst. 1997 Jan 1;89(1):66-71. doi: 10.1093/jnci/89.1.66. J Natl Cancer Inst. 1997. PMID: 8978408
-
p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.J Natl Cancer Inst. 1993 Oct 20;85(20):1657-69. doi: 10.1093/jnci/85.20.1657. J Natl Cancer Inst. 1993. PMID: 7692074
-
P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.Br J Cancer. 1996 Jul;74(2):264-8. doi: 10.1038/bjc.1996.349. Br J Cancer. 1996. PMID: 8688333 Free PMC article.
-
Alteration of the tumor suppressor gene p53 in a high fraction of hormone refractory prostate cancer.J Urol. 1995 Aug;154(2 Pt 1):414-21. doi: 10.1097/00005392-199508000-00024. J Urol. 1995. PMID: 7609105 Review.
-
Use of a yeast assay to detect functional alterations in p53 in prostate cancer: review and future directions.Prostate. 1999 Oct 1;41(2):134-42. doi: 10.1002/(sici)1097-0045(19991001)41:2<134::aid-pros8>3.0.co;2-e. Prostate. 1999. PMID: 10477910 Review.
Cited by
-
Significance of p53 and ki-67 expression in prostate cancer.Urol Ann. 2015 Oct-Dec;7(4):488-93. doi: 10.4103/0974-7796.158507. Urol Ann. 2015. PMID: 26692671 Free PMC article.
-
Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.PLoS One. 2018 Oct 15;13(10):e0205837. doi: 10.1371/journal.pone.0205837. eCollection 2018. PLoS One. 2018. PMID: 30321230 Free PMC article.
-
Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.Am J Pathol. 1997 May;150(5):1511-21. Am J Pathol. 1997. PMID: 9137077 Free PMC article. Review. No abstract available.
-
A microdissection approach to detect molecular markers during progression of prostate cancer.Br J Cancer. 1995 Oct;72(4):946-51. doi: 10.1038/bjc.1995.439. Br J Cancer. 1995. PMID: 7547246 Free PMC article.
-
Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.Am J Pathol. 1995 Oct;147(4):1112-22. Am J Pathol. 1995. PMID: 7573356 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous